Podcasts about Chief scientific officer

John Maytham speaks to Jane Muncke, one of the authors of a Lancet Review on the impact of plastic on human health, and Chief Scientific Officer at the Food Packaging Forum, about the growing plastic crisis. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Welcome back to Research Renaissance, presented by the Karen Toffler Charitable Trust. In this episode, host Deborah Westphal explores the cutting edge of rare disease research with special guests Andrew Rosen, CEO of the National Ataxia Foundation (NAF), and Dr. Lauren Moore, NAF's Chief Scientific Officer.Together, they unpack how the NAF has evolved from a small support-focused nonprofit into a strategic, science-driven organization that's advancing treatments and reshaping what's possible for people living with ataxia—a rare, progressive neurological condition affecting movement and coordination.

Dave Snowden is the Founder and Chief Scientific Officer of The Cynefin Company. The Cynefin Company is an action research and development hub that uses complexity science principles to provide organisations with better tools and frameworks to solve complex problems and improve management practices. In this episode, Dave reveals how the Cynefin Framework aids in people management and how leaders can use it to distinguish between ordered, complex, and chaotic systems. He also addresses the limitations of traditional systems thinking and the role of AI in modern decision-making. Resources and links: The Cynefin Company website Dave Snowden on X Dave Snowden on Bluesky Dave Snowden on LinkedIn Connect: Simplifying Complexity on X Simplifying Complexity on YouTube Sean Brady on X Sean Brady on LinkedIn Brady Heywood website This show is produced in collaboration with Wavelength Creative. Visit wavelengthcreative.com for more information.

If you've ever seen a medical drama, you know how intense it gets when a patient is bleeding and doctors have to act fast. But in real life, understanding why someone is bleeding—and how best to stop it—isn't always straightforward. That's where Dr. Francesco Viola's work at HemoSonics comes in.HemoSonics provides a solution for doctors to get a clear picture of how a patient's blood is clotting. Instead of waiting for slow lab results or guessing which blood products to give, doctors can now make informed decisions in real time—right at the bedside. Dr. Viola brings a unique blend of engineering precision and clinical vision to HemoSonics. With a background in biomedical engineering and more than a decade of experience in medical ultrasound, signal processing, and instrumentation, he's led the charge in developing HemoSonics' groundbreaking Sonic Estimation of Elasticity via Resonance (SEER) technology.Under his leadership, HemoSonics is addressing one of the most critical gaps in patient care: the need for fast, accurate, and actionable blood clotting data—whether during surgery, in the ICU, or at the point of trauma. Qualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez

Steve Gruber is joined by Dr. Peter McCullough, Chief Scientific Officer at The Wellness Company, to discuss a groundbreaking new study suggesting chemotherapy might reactivate dormant cancer cells, and what that means for patients. They dive into Big Pharma's reluctance to explore low-cost alternatives, the emerging potential of ivermectin as a cancer treatment, and practical advice for parasite cleansing and protecting against the spike in tick bites this year.   Visit twc.health/GRUBER, Promo Code GRUBER Saves 10%.  

Dr. Patel is a physician-leader and interdisciplinary innovator working at the forefront of healthcare transformation, AI-powered clinical tools, and science-based wellness. He is a NIMH-funded research fellow in Child and Adolescent Psychiatry at Brown University, and the Founding Medical Director and Director of AI Decision Support at Sully.ai, a pioneering platform delivering intelligent clinical support tools for physicians. At Sully.ai, Dr. Patel helps guide the design and implementation of AI-powered clinician support systems that are already being used across tens of millions of patient visits. He focuses on ensuring these tools improve care quality, reduce errors, and align with real-world clinical workflows and physician trust. As a clinician and strategist, he brings a human-centered lens to healthcare technology — grounded in both evidence and empathy. Beyond AI, Dr. Patel is also the Co-Founder, CEO, and Chief Scientific Officer of myPEAK, an award-winning vegan nutrition and wellness company focused on creating high-performance, science-backed vegan supplements. Founded when he was in medical school, myPEAK has grown rapidly under his leadership, earning recognition for its clean formulations, sustainability focus, and triple-digit growth in the health optimization space. Dr. Patel earned his undergraduate degree at Vadnerbilt University where he studied philosophy, religious studies, and psychology, MD and psychiatry residency from the Medical College of Georgia, and a child & adolescent psychiatry fellowship at Brown University. He also completed a Healthcare MBA from the University of Arizona, and pursued advanced specializations in AI in Healthcare from Stanford and Vanderbilt and Hopkins. His work bridges the clinical, strategic, and entrepreneurial realms — with a vision for reshaping healthcare from the inside out. His forthcoming book, Trauma Transformed, explores trauma, resilience, and healing through the lens of psychiatry, neuroscience, and integrative care — offering fresh insights into how we grow through adversity. Whether discussing healthcare innovation, physician entrepreneurship, trauma recovery, or high-performance wellness, Dr. Patel brings a rare, cross-disciplinary perspective to every conversation — one rooted in lived clinical experience, system-level thinking, and a mission to humanize the future of healthcare.

Healthy aging has been identified as an important trend that consumer healthcare companies need to respond to. According to founder and managing director of UK firm Prime Fifty, Max Gowland, innovating in this area requires understanding the science behind healthy aging and offering consumers specific and efficacious products, rather than catch-all solutions. In this episode of HBW Insight's Over the Counter podcast, Gowland dives into some of the science behind targeted nutrition for over fifties and explains why appearing on TV shopping channels like QVC has offered a useful way to communicate these benefits to older consumers. Timestamps: 2:00 – Introductions 5:45 – Leveraging consumer health industry experience 8:15 – Prevention is key 10:30 – Competing for shelf space 13:30 – Be a specialist not a generalist 14:30 – Selling via shopping TV 17:30 – Why science and quality is important in healthy aging supplementation 24:00 – Addressing musculoskeletal health 32:00 – Getting your claims right 36:00 – What's next for Prime Fifty Guest Bio: Max Gowland is a PhD-qualified biochemist with over 40 years' experience in health and nutrition. He is a leading expert on shaping the nation on providing supplements for 50+ and his focus includes helping support longevity through supplementation to support bone health, skin, hair, nails and more. Having worked with many large companies, Gowland founded Prime Fifty focusing on healthy ageing and currently serves as Chief Scientific Officer at FutureYou Cambridge. Gowland regularly appears on QVC and at industry events to promote evidence-based nutritional support for midlife and beyond.

Whether you're living with type 1 diabetes, know someone who is, or simply want to understand it better; what we cover today could change the way you see it.  In today's episode we are joined by Dorota Pawlak, Chief Scientific Officer at Breakthrough T1D, an organisation working to create a world without type 1 diabetes (T1D). These guys are funding groundbreaking research, supporting families, and advocating for better health policies.  We unpack what type 1 diabetes really is, the early signs most people miss and the life changing research that is rewriting the future of T1D.  You'll learn: The difference between type 1 and type 2 diabetes Early signs and symptoms of T1D every parent (and family) should know  How far T1D treatment and care has come over the past 10 years  The current clinical trials making breakthroughs and what's next… How early detection is saving lives (and how you can access it)  … and SO much more. Watch the YouTube Version of the Podcast here. Check out Dorota on LinkedIn here https://www.linkedin.com/in/dorota-pawlak-phd-34a378b/ Want to know more about Breakthrough T1D? Check them out here: Website: breakthrought1d.org.auInstagram: @breakthrought1dauFacebook: Breakthrough T1D AUYouTube: Breakthrough T1D Australiahttps://type1screen.org/ Service Dorota Mentioned: https://type1screen.org/  If you have any burning questions and want me to answer them, join us on our Facebook page - SynxBody Squad! We do everything from Weekly Q&As, health, wellness and fitness tips as well as exclusive first looks at our new products (with the opportunity to test and review!) Click here to join. Ready to take a step in the right direction and look after future you? Check out the products that will keep your body in Synx here - www.synxbody.com And if you want to see more of the behind the scenes OR you loved the episode let us know over on instagram at @synxbody and @rachael.ferguson  or on TikTok here @synxbody 

In this episode of Derms and Conditions, host James Q. Del Rosso, DO, sits down with Jason Hawkes, MD, Chief Scientific Officer at Oregon Medical Research Center, to explore the role of dupilumab in chronic spontaneous urticaria (CSU), a condition historically managed outside dermatology. They begin with the immunologic underpinnings of CSU, explaining the role of IL-4 and IL-13 in driving mast cell activation and the role of IL-31 in itch. Since dupilumab blocks these key cytokines, it can disrupt the disease process at multiple levels, from antibody formation to immune cell recruitment. They discuss the growing comfort among dermatologists in treating CSU now that a familiar and accessible agent like dupilumab is available, especially when compared to omalizumab, which has been limited by concerns over anaphylaxis and practice logistics. They next address real-world considerations, including the time dupilumab takes to work, the use of short-term corticosteroids, and the need for personalized treatment approaches. They caution against over-reliance on corticosteroids and discuss alternative bridging therapies like cyclosporine or methotrexate for severe cases. The episode also covers dosing nuances, patient selection, how to distinguish CSU from other urticaria types, and the importance of setting expectations. Dr Hawkes shares his experience with long-term efficacy, noting minimal loss of response among his patients. Listen to this episode for more clinical insights on dupilumab as a key treatment in managing chronic spontaneous urticaria, including considerations around patient selection, duration of therapy, and long-term disease control.

One week ago, on July 15, U.S. Senator Ron Johnson of Wisconsin held a hearing titled: Voices of the Vaccine Injured. Senator Johnson is the Chairman of the Permanent Subcommittee on Investigations. Five witnesses gave their testimonies related to vaccine injuries and two witnesses spoke on vaccine efficacy. Interestingly, on the day of this hearing, WND.com released a story concerning an undercover video by the O'Keefe Media Group. They allegedly caught a scientist with Johnson & Johnson on undercover video who indicated that proper testing was not done on the COVID vaccines. This should surprise no one as there have been many individuals who've experienced severe health consequences due to certain vaccines. Unfortunately, their stories are largely ignored. This edition of Crosstalk brings such stories to light as you'll hear testimony from the following individuals: Emily Tarsell, whose daughter Christina died following the Gardasil vaccination. Dr. Brian Hooker, Chief Scientific Officer for Children's Health Defense, gave testimony concerning his son Steven. Dr. Robert Sullivan, a board certified anesthesiologist who himself was vaccine injured. Polly Tommey, the mother of a son who was vaccine injured. Krystal Cordingley, whose son Corbyn, died after a flu vaccination.

Being a pharmacist is exciting–as long as you're willing to try new things. These are wise words from my returning guest on today's podcast, who has been paving the way for integrative pharmacy. Dr. Swathi Varanasi is an award-winning pharmacist passionate about the intersection of personalized medicine, patient outcomes, and innovation. With experience spanning patient care, biotech, research, academia, and consumer product goods, Dr. Swathi has paved the way for healthcare professionals to pursue non-traditional career paths through creating postdoctoral training programs, industry internships, and online educational programs. She co-founded and serves as Chief Scientific Officer of the Life Sciences Division at Element Apothec, and serves as a Principal Investigator at contract research organization, Citruslabs. Dr. Swathi received her Doctor of Pharmacy (PharmD) at the Medical University of South Carolina and Bachelor of Arts (BA) at Carleton College. She was the first-ever pharmacist in the United States with formal residency training to specialize in integrative medicine and preventative health. She also completed a postdoctoral fellowship in Medical Affairs in biotech and has training in nutrition from Cornell University. Dr. Swathi has served as faculty and guest lectures at colleges and universities across the country. She is an advisor and consultant for a number of for-profit and nonprofit organizations aiming to make the world a healthier place for us to live–and thrive. She has been published in peer-reviewed academic journals and featured in Yahoo, mindbodygreen, Well+Good, Entrepreneur, Forbes Health, and more. In 2023, Dr. Swathi was voted one of the 50 Most Influential Leaders in Pharmacy. Connect with Dr. Swathi via: Email: swathimvaranasi@gmail.com  FB: Doctor Swathi  IG: @drswathivaranasi Linked In:Dr. Swathi Varanasi  Check out our earlier episode here: https://www.marinabuksov.com/s03e03-paving-the-unconventional-path-with-integrative-pharmacist-dr-swathi-varanasi/ 

One week ago, on July 15, U.S. Senator Ron Johnson of Wisconsin held a hearing titled: Voices of the Vaccine Injured. Senator Johnson is the Chairman of the Permanent Subcommittee on Investigations. Five witnesses gave their testimonies related to vaccine injuries and two witnesses spoke on vaccine efficacy. Interestingly, on the day of this hearing, WND.com released a story concerning an undercover video by the O'Keefe Media Group. They allegedly caught a scientist with Johnson & Johnson on undercover video who indicated that proper testing was not done on the COVID vaccines. This should surprise no one as there have been many individuals who've experienced severe health consequences due to certain vaccines. Unfortunately, their stories are largely ignored. This edition of Crosstalk brings such stories to light as you'll hear testimony from the following individuals: Emily Tarsell, whose daughter Christina died following the Gardasil vaccination. Dr. Brian Hooker, Chief Scientific Officer for Children's Health Defense, gave testimony concerning his son Steven. Dr. Robert Sullivan, a board certified anesthesiologist who himself was vaccine injured. Polly Tommey, the mother of a son who was vaccine injured. Krystal Cordingley, whose son Corbyn, died after a flu vaccination.

Send us a textDr. Lara Nyman, Ph.D. is the Vice President of Research & Discovery at AG1 ( https://drinkag1.com/learn/research/scientific-research ), responsible for leading the company's innovative research efforts to develop cutting-edge nutritional products. In this role, she oversees the research and development of new formulations, ensures the scientific integrity of product claims, and collaborates with cross-functional teams to drive product innovation. Dr. Nyman previously served as the Chief Scientific Officer at Weo, a water augmentation company, providing strategic guidance and scientific oversight to the company's product development and research initiatives, working closely with their R&D team to identify emerging trends, evaluate new technologies, and translate scientific insights into compelling consumer offerings.Prior to Weo, Dr. Nyman served as Senior Principal Scientist in the Claims Center of Excellence for Consumer Health & Wellness at PepsiCo, leveraging her deep understanding of consumer needs and scientific principles to develop innovative, evidence-based claims for the company's health and wellness products. Dr. Nyman holds a Master of Science (MS) in Exercise Physiology from Southern Connecticut State University, a Ph.D. in Cellular and Molecular Physiology from University of Alabama at Birmingham, and was a Post-Doctoral Fellow, Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism at Vanderbilt University School of Medicine.#LaraNyman #AG1 #AthleticGreens #ExercisePhysiology #Endocrinology #Metabolism #FoundationalNutrition #Wellness #NutrientGaps #NutrientSynergy #Nutrigenomics #Synbiotics #Microbiome #WholeFood #Superfoods #Probiotics #Adaptogens  #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

In this powerful return episode, Michele Hughes welcomes back Ryan Smith, founder and Chief Scientific Officer of TruDiagnostic. Formerly the CEO of Tailor Made Compounding, Ryan transitioned his focus from peptides to epigenetic science, becoming a leading force in the field of biological aging. This episode is a deep-dive tutorial on biological age testing, DNA methylation, and how epigenetics can give us control over the aging process.Ryan explains the difference between chronological and biological age, the power of DNA methylation data, and the cutting-edge technology behind TruDiagnostic's comprehensive testing. Listeners will also learn about telomeres, organ-specific age reports, and the groundbreaking “Rejuvenation Olympics.” Michele shares her own test results and explores how these tools offer insight into one's aging trajectory and risk factors for chronic disease.Whether you're new to biohacking or a longevity enthusiast, this episode offers a front-row seat to the future of preventative health.

In this episode of the Scrum.org Community Podcast, host Dave West sits down with Tyson Bertmaring, Head of Partnership Success and Adrian Veres, Chief Scientific Officer from Dyno Therapeutics, a cutting-edge gene therapy startup. They share how Dyno applies the ideas of the Agile Product Operating Model (APOM) to complex scientific research—shifting from traditional structures to empowered, cross-functional teams aligned to clear goals.You will hear how Dyno integrates APOM principles such as product-centric team design, continuous planning, and aligned incentives to drive innovation in a high-stakes environment. The conversation highlights how adopting a product mindset, supported by an enabling organization, creates the conditions for focus, adaptability, and breakthrough scientific results. 

Today, you will hear information about testing your male partner with a relatively new test called SpermQT. This week, the Fertility Docs, Dr. Carrie Bedient from the Fertility Center of Las Vegas, Dr. Susan Hudson from Texas Fertility Center, and Dr. Abby Eblen from Nashville Fertility Center welcome a groundbreaking guest: Dr. Kristen Brogaard, Chief Scientific Officer and Founder of Path Fertility. Kristen joins the Docs to discuss SpermQT, one of the first major innovations in male fertility testing in years. SpermQT goes beyond a traditional semen analysis to assess sperm DNA and determine whether sperm is capable of fertilizing an egg. If the SpermQT test is abnormal, it strongly suggests that natural conception or IUI will likely fail, making IVF the recommended next step.Kristen shares how Path Fertility is conducting multiple studies to evaluate pregnancy outcomes when the SpermQT test is applied to men whose partners conceive naturally or through IUI and aims to track pregnancy through delivery. Future analysis in the IVF lab will evaluate fertilization and embryo development in men with normal versus abnormal testing. SpermQT is helping to redefine how we understand male fertility, challenging the outdated assumption that a normal semen analysis equals fertility. If you order the test the DISCOUNT CODE is FDU. ReceptivaDx sponsored this podcast.

Kiran Krishnan is a research microbiologist and Chief Scientific Officer at Just Thrive, with expertise in gut health, probiotics, and the human microbiome.15 Daily Steps to Lose Weight and Prevent Disease PDF: https://bit.ly/46XTn8f - Get my FREE eBook now!Subscribe to The Genius Life on YouTube! - http://youtube.com/maxlugavereWatch my new documentary Little Empty Boxes - https://www.maxlugavere.com/filmThis episode is proudly sponsored by:JustThrive makes high quality probiotics with mental health in mind. Get 20% your first 90 day bottle when you go to https://justthrivehealth.com/GENIUS and use code GENIUSLIFE at checkout!Struggling with diet culture confusion? Fay connects you with a registered dietitian—often for $0 with insurance. To create a personalized, evidence-based plan that actually works, head to FayNutrition.com/GENIUS.Pique makes quadruple toxin-screened, cold extracted, and uber-delicious matcha for an all-day energy boost without the jitters! Head to http://piquelife.com/genius for up to 15% off.BiOptimizers makes a magnesium mega-supplement containing 7 forms of magnesium. They also make great digestive support aids. Head to ⁠bioptimizers.com/genius⁠ and use code GENIUS10 for 10% off.Shopify makes it easy to accept payments, manage orders, and build relationships with customers (cha-ching!). Get everything you need to sell in person and online at http://shopify.com/genius and get a one-dollar-per-month trial period!

Ying Tam, Chief Scientific Officer at Acuitas Therapeutics, discusses the company's role in delivering the first personalized CRISPR gene editing treatment to an infant with CPS-1, achieving treatment in just six months from diagnosis. Tam shares insights on evolving lipid nanoparticle technology beyond COVID vaccines, including LNPs that allow for next-generation immune-targeting delivery that is 10x more potent, and progress in delivering genetic medicines to stem cells and solid tumors. He also addresses the challenges of repeat dosing, a new biodegradable LNP formulation, and expanding genetic medicine beyond the liver to treat blood disorders and cancer.

This episode of VHHA's Patients Come First podcast features Dr. Saul Karpen, Chief Scientific Officer of the Virginia Commonwealth University Stravitz-Sanyal Institute for Liver Disease and Metabolic Health and President-Elect of the American Association for the Study of Liver Disease. He joins us for a conversation about his work, new pediatric guidelines developed to detect a life-threatening liver disease in infants, and more. Send questions, comments, feedback, or guest suggestions to pcfpodcast@vhha.com or contact on X (Twitter) or Instagram using the #PatientsComeFirst hashtag.

As AI systems rapidly advance and enhance data processing, experts are taking note of their surprising capabilities. But what does this sudden explosion of AI mean for modern society? What vulnerabilities should we be watching for? Dr. Matthew Lungren joins the podcast to shed light on this ever-changing landscape… This discussion covers: Why 2023 was the tipping point for AI applications. The difference between “narrow” and “generative” AI. How AI has taught itself various useful functions. The ways that AI can automate complex, text-based workflows. Dr. Lungren is the Chief Scientific Officer for Microsoft Health & Life Sciences. Currently, his work focuses on translating cutting-edge technology into innovative healthcare applications. As a physician and clinical machine learning researcher, he holds ongoing collaborative research and teaching roles as an adjunct professor at Stanford University. Dr. Lungren is the author of over 200 publications, with work spanning multi-modal data fusion, computer vision and NLP in healthcare, machine learning for public health screening, generative AI applications in medicine, and more. He also has experience advising early-stage startups and Fortune 500 companies on healthcare AI development and unique market strategies. His work has been featured by NPR, Vice News, and Scientific American, and he is a regular speaker at leading national and international conferences on AI in healthcare. Follow along with Dr. Lungren's work on X @mattlungrenMD! Episode also available on Apple Podcasts: http://apple.co/30PvU9C Keep up with Matthew Lungren socials here: Tiktok: https://www.tiktok.com/@dr.mattlungren  Instagram: https://www.instagram.com/matt_lungren/  YouTube: https://www.youtube.com/@mattlungrenmd 

This is the latest episode of the free DDW narrated podcast, titled "UK Spotlight: Innovation and discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “Where is the drug discovery expertise happening in the UK?”, “From the top: Dr Martin Main, Medicines Discovery Catapult”, and “Meet the Researcher: Molly Stevens, Oxford University and Imperial”. In the first article, I highlight the research taking place and where this is happening in the UK, a long-established hub for drug discovery expertise worldwide.  In the second article, I spoke with Dr Martin Main, Chief Scientific Officer, Medicines Discovery Catapult, in the From the Top series.   In the third article, I spoke with Molly Stevens, John Black Professor at Oxford University and Research Director for Biomedical Materials at Imperial College London, as part of the Meet the Researcher series.

Peter A McCullough, MD, MPH, Chief Scientific Officer, TWC, twc.health/GRUBER, Promo Code GRUBER Saves 10% The new COVID variant has a nasty new symptom that has led the media to dub it as the “Razor Blade Throat” variant It feels a little coincidental that at a time that pharmaceutical profits are dropping and COVID vaccine boosters are at an all time low that this new scary sounding variant is out there  

As our population ages, are we designing technology that truly meets their needs, or just what we think they need?In this episode of Straight Out of Health IT, Dr. Jennifer Boger, Chief Scientific Officer at ESGai Technologies, shares how her love for problem-solving and a personal connection to dementia led her into engineering and health technology. She underscores the flaws in current healthcare systems, particularly their focus on acute care over prevention and quality of life, and calls for a shift toward more holistic, person-centered approaches. Dr. Boger emphasizes that quality of life, though hard to quantify, should be a primary goal of healthcare. She also discusses the importance of designing inclusive technologies that are intuitive and respectful, noting that simplicity should not be mistaken for infantilization, especially when creating tools for older adults.Dr. Jennifer Boger explores the concept of ambient, zero-effort technologies, tools that are ubiquitous, accessible, and require minimal user effort. She and host Christopher Kunney agree that aging populations need technology that is easy to use without sacrificing dignity or privacy. They raise concerns about digital marginalization, warning that people who can't or choose not to use digital systems risk being excluded from essential services and even from AI-generated insights. Dr. Boger stresses the need for transparency in how data is collected and used, proposing clearer, more accessible summaries of privacy policies to empower users.Dr. Boger believes that while the concept of “considerate AI”, systems designed with ethical frameworks and human understanding in mind, holds promise, it is challenging to implement and will require time, patience, and brave, collaborative spaces. She envisions AI that supports rather than replaces human decision-making by prompting reflection and enhancing objectivity. Looking ahead, she sees natural language interfaces as a game-changer for independent living. For those entering the field, her advice is to connect directly with the people they're designing for, involving them early and often to ensure solutions are grounded in real-world needs and experiences.Tune in to learn how assistive technologies, ethical AI, and human-centered design can reshape aging, healthcare, and independent living! 

Experts warn AI and transhumanist biotech may render humans economically inessential, creating a “useless class” as machines outpace human intelligence. Surveillance of biological data by governments and corporations – mostly gathered through mass vaccination programs – could lead to total control, as your digital and bio data are decoded to manipulate decisions with an algorithm tailored to your specific beliefs and profile. Many fear a future “digital dictatorship” where surveillance strips away all privacy and enables streamlined control of citizens by corporations and governments. Dr. Peter McCullough examines the NB.1.8.1 variant's rapid rise and USDA's poultry vaccination plans, questioning COVID vaccine efficacy claims. Joe Allen discusses AI's cognitive impacts, misinformation about transhumanism, and the latest case of AI-driven false accusations. Dr. Peter McCullough is a renowned internist, cardiologist, and Chief Scientific Officer of The Wellness Company. He is co-author of the frequently-banned book The Courage to Face COVID-19. More at https://x.com/P_McCulloughMD⠀Joe Allen is the Transhumanism Editor for War Room and author of Dark Aeon: Transhumanism And The War Against Humanity. He's an expert in tech and religion. More at https://x.com/JOEBOTxyz 「 SUPPORT OUR SPONSORS 」 Find out more about the brands that make this show possible and get special discounts on Dr. Drew's favorite products at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/sponsors⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • ACTIVE SKIN REPAIR - Repair skin faster with more of the molecule your body creates naturally! Hypochlorous (HOCl) is produced by white blood cells to support healing – and no sting. Get 20% off at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/skinrepair⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • VSHREDMD – Formulated by Dr. Drew: The Science of Cellular Health + World-Class Training Programs, Premium Content, and 1-1 Training with Certified V Shred Coaches! More at ⁠⁠⁠⁠https://vshredmd.com/⁠⁠⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 「 MEDICAL NOTE 」 Portions of this program may examine countervailing views on important medical issues. Always consult your physician before making any decisions about your health. 「 ABOUT THE SHOW 」 Ask Dr. Drew is produced by Kaleb Nation (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠) and Susan Pinsky (⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/firstladyoflov⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠e⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠). This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today we have the second installment of our interview with Dr. Michael A. Schmidt, the founder, CEO, and Chief Scientific Officer of Sovaris Aerospace, a company focused on assessments and solutions applied to humans in space and extreme environments on Earth. In today's interview, we talk to Michael about NASA's plans to send humans to Mars and build permanent colonies on the Moon and Mars. We also talk to Michael about his recent book, “Building a Space-Faring Civilization,” which addresses the challenges of civilian spaceflight and the construction of space settlements. In part one of our interview, Episode 182, we talked with Michael about his pioneering work in the field of precision medicine and how he has used it to improve the cognitive and physical performance of astronauts as well as NBA, NFL players and Special Operations forces. In addition to his work with Sovaris, Michael also is a professor of aerospace medicine at the University of Central Florida College of Medicine, one of the few programs in the U.S. that offers a medical residency in aerospace medicine. Show notes: [00:03:00] Dawn picks up our interview from where we left off in part one, discussing the Human Research Program for Civilian Spaceflight. She goes on to mention that Chris Mason at Cornell University has a biobank of 1,500 samples across 22 astronauts and seven missions, and that these samples will lead to deeper insights on the effects of spaceflight on humans. Dawn switches gears to ask Michael about the cognitive and physical challenges of spaceflight over long duration missions. [00:13:03] Following up on the cognitive challenges of long duration spaceflight, Ken mentions that the hippocampus, the primary memory center of the brain, has a relatively low radiation threshold compared to other tissues in the brain. Ken asks Michael to touch on the vulnerability of specialized brain tissues to radiation, particularly in the context of a long duration spaceflight to Mars. [00:21:53] Ken mentions that it is understood that the APOE4/4 genotype is associated with impaired cognitive performance under certain circumstances and an elevated risk of dementia. While it is currently unknown whether APOE4/4 has any correlation of increased risk associated with cognitive impact resultant from environmental exposure due to spaceflight, Ken highlights the concern with sending APOE4/4-positive astronauts on long duration spaceflights without knowing the risks. [00:29:26] Ken notes the worsened cognitive impacts resultant from medical radiation, and while therapeutic radiation is different than radiation experienced by astronauts, these results give some indication of the effects astronauts might experience. [00:33:27] Dawn mentions that we recently had planetary scientist and director of NASA's Haughton-Mars project, Pascal Lee, on the podcast, who explained his view that since there are so many engineering and biological challenges with going to Mars, we should take a more measured approach to a Mars mission, perhaps even beginning with a roundtrip to Mars rather than landing on our first visit. Dawn asks Michael what his thoughts are on this approach. [00:37:29] Ken shifts the discussion to the subject of one of Mars' moons, Phobos, and its potential role in a Mars mission. [00:40:30] Dawn pivots to talk about Michael's Book “Building a Space-Faring Civilization: Advancing the Renaissance of Science, Medicine and Human Performance in Civilian Spaceflight.” Dawn asks Michael to talk about the chapter concerning the question of space radiation from the standpoint of precision medicine. [00:55:12] Dawn asks Michael to talk about the lack of appreciation people have for the fact that a Mars mission would be the most dangerous thing we've ever done. [00:59:06] Ken mentions that Michael has worked with a lot of organizations, including Space X, which has a program, the Space X Mars Colonization Program,

What every healthcare leader should know is at the heart of this episode featuring Dr. Todd Brinton, Chief Scientific Officer at Edwards Lifesciences and a leading figure in medtech innovation. Dr. Brinton's journey began in a sixth-grade classroom, where a fascination with the heart sparked a lifelong passion for both medicine and technology. That early curiosity led him to pursue engineering, medicine, and eventually leadership in heart health. Before becoming a recognized leader, Dr. Brinton faced the same questions many young professionals do—wondering if he belonged, and whether he could move from engineering into medicine. Throughout his career, mentors played a crucial role in helping him find his potential, and setbacks became opportunities for growth. These experiences shaped his approach to leadership, resilience, and innovation in healthcare. Dr. Brinton discusses lessons learned from building teams, founding companies like Shockwave Medical and BioParadox, and making difficult choices as both a physician and entrepreneur. He shares why honesty and kindness matter in leadership, how to create meaningful mentor relationships, and what it really takes to move ideas from the clinic to the corporate world. The conversation covers why embracing mistakes is essential for progress, why people—not just technology—will define the future of health innovation, and advice for those building their own path in healthcare. Whether you're leading a startup, managing a hospital team, or just starting your career, Dr. Brinton's story offers practical insight for every stage. Hear directly from Dr. Todd Brinton as he joins Christine Winoto for a candid discussion about career pivots, mentorship, and the realities of healthcare leadership, brought to you by the UCSF Rosenman Institute. For more on healthcare innovation, check out What 2 Billion Data Points Can Tell Us: James Mault on Smarter Care. Do you have thoughts on this episode or ideas for future guests? We'd love to hear from you. Email us at hello@rosenmaninstitute.org.

Dr. Ebru Karpuzoglu is an immunologist and molecular medicine expert, and the Chief Scientific Officer and CEO of Aveseena. Dr. Karpuzoglu discusses "inflammaging," a condition where inflammation and premature aging occur simultaneously, triggered by factors such as stress, diet, and harsh skincare practices. Dr. Karpuzoglu highlights the skin's role as the first line of immune defense, protected by its microbiome and immune system. Disclosure: Dr Ebru is an executive for a for profit skin care product and service line. Learn more about Dr. Ebru and her company Aveseena here: https://www.aveseena.com/about-us/

In this episode, we sit down with Dr. Mark Esser, the inaugural Chief Scientific Officer of UVA's new Paul and Diane Manning Institute of Biotechnology. Dr. Esser, a renowned expert in immunology and vaccine development, shares his journey from AstraZeneca to leading this ambitious institute. With a vision to revolutionize healthcare and accelerate the development of life-saving treatments, Mark discusses fostering innovation, attracting biotech companies to Virginia, and the future of personalized medicine.

In this episode of The Pet Food Science Podcast Show, Lars Reimann and Kari Nichols from Eurofins Scientific explain the science behind analytical testing and regulatory compliance in the pet food world. They talk through the new label modernization rules, why ingredient consistency matters, and what makes testing fiber and shelf life so tricky. You'll also hear how lab methods are adapting to keep up with industry demands. Tune in now on your favorite podcast platform!"Crude fiber remains a necessary component in determining calories from carbohydrates, despite no longer being listed on pet food product labels." - Kari NicholsMeet the guests: Lars Reimann, Chief Scientific Officer at Eurofins Scientific, brings over 35 years of experience helping pet food clients navigate analytical, nutritional, and regulatory testing.Kari Nichols, Vertical Business Development Manager for Pet & Animal Nutrition, has 11 years of experience in lab services, specializing in food safety and label compliance.Dr. James Templeman & Lindsay Meyers: Raw Pet Food | Ep. 96Liked this one? Don't stop now — Here's what we think you'll love!What will you learn:(00:00) Highlight(01:01) Introduction(03:37) Labeling regulation changes(06:00) Dietary vs crude fiber(12:54) Fiber testing methods(28:49) Analytical methods matter(36:57) Shelf life evaluations(42:47) Final QuestionsThe Pet Food Science Podcast Show is trusted and supported by innovative companies like:* Trouw Nutrition* Kemin- EW Nutrition- Wilbur-Ellis Nutrition- ICC- Biorigin- Scoular

Jackie von Salm, a chemist and Chief Scientific Officer at Psilera, shares her father Terry's journey with FTD. We loved how Jackie was so raw + honest about family dynamics, becoming Terry's POA in her 20s, and how she learned how to be direct + honest in how she felt and what she needed while caregiving. You can learn more about what she's up to at Psilera here. You can also hear us chat all about their Research Summit this year on Patreon - along with an extended version of this episode.Patreon⁠⁠⁠⁠⁠ - join us ⁠⁠⁠⁠⁠www.patreon.com/remembermecommunity⁠⁠⁠⁠⁠ - you get exclusive content and it's a great way to support the show!----------Special thank you to today's sponsor ⁠⁠AVIADOBIO⁠⁠.If you're curious about anything RM, we'd love to connect with you on ⁠⁠⁠⁠⁠⁠⁠⁠Instagram, and visit ⁠⁠⁠⁠⁠our website at⁠⁠⁠⁠⁠⁠⁠⁠ www.remembermeftd.com⁠⁠⁠⁠⁠⁠⁠⁠, all the latest updates! ------Remember Me Podcast + Community is here to offer hope + human connection for families, caregivers, and individuals impacted by Frontotemporal Dementia (FTD). Always, always accept the good.

Peter Ordentlich, Chief Scientific Officer and Founder at Syndax Pharmaceuticals, a clinical oncology company, is focused on developing precision medicine approaches to treat cancer and chronic graft-versus-host disease. The menin protein plays a critical role in driving certain types of blood cancers, and the Synex therapy is a menin inhibitor that can disrupt this cancer-driving pathway. The platform is also developing an antibody addressing the unmet needs in cGVHD to reduce the disease-driving macrophages. Peter explains, "Syndax is a clinical oncology company, which means we're focused primarily on cancer, and we're primarily doing clinical development. We started the company really looking at resistance pathways to developing cancer, and we've been focused on two main areas. One in the indication space of leukemia, which are certain types of blood cancers, and that's with a program we have around the small molecule drug called revumenib. We are also focused in another area of diseases called chronic graft-versus-host disease. These are diseases that happen post-stem cell transplant, and there we're developing an antibody called axatilimab. And so those two programs are really what we've been focusing on for the last five or six years and have led to each of those drugs." "So menin is a very interesting protein, and basically what this is, it's called a scaffold protein. And you can imagine a scaffold, just something you build things upon. And so menin interacts with DNA through a variety of other factors, and you build on top of this a complex of other proteins that can turn genes on and off. And in the case of certain types of leukemias, the mutation that creates certain other cancer-causing proteins binds to menin. That's what drives certain genes that drive leukemia to always be turned on. And so what we've tried to do and others have tried to do is disrupt that interaction and essentially cause the scaffold to fall apart. And when that falls apart, you can no longer keep those genes on that drive leukemia, and instead, you have genes that essentially cause the cell to stop growing."  #SyndaxPharma #AcuteLeukemia #cGHVD #Oncology #PrecisionMedicine #Menin #MeninInhibitors syndax.com Download the transcript here

Peter Ordentlich, Chief Scientific Officer and Founder at Syndax Pharmaceuticals, a clinical oncology company, is focused on developing precision medicine approaches to treat cancer and chronic graft-versus-host disease. The menin protein plays a critical role in driving certain types of blood cancers, and the Synex therapy is a menin inhibitor that can disrupt this cancer-driving pathway. The platform is also developing an antibody addressing the unmet needs in cGVHD to reduce the disease-driving macrophages. Peter explains, "Syndax is a clinical oncology company, which means we're focused primarily on cancer, and we're primarily doing clinical development. We started the company really looking at resistance pathways to developing cancer, and we've been focused on two main areas. One in the indication space of leukemia, which are certain types of blood cancers, and that's with a program we have around the small molecule drug called revumenib. We are also focused in another area of diseases called chronic graft-versus-host disease. These are diseases that happen post-stem cell transplant, and there we're developing an antibody called axatilimab. And so those two programs are really what we've been focusing on for the last five or six years and have led to each of those drugs." "So menin is a very interesting protein, and basically what this is, it's called a scaffold protein. And you can imagine a scaffold, just something you build things upon. And so menin interacts with DNA through a variety of other factors, and you build on top of this a complex of other proteins that can turn genes on and off. And in the case of certain types of leukemias, the mutation that creates certain other cancer-causing proteins binds to menin. That's what drives certain genes that drive leukemia to always be turned on. And so what we've tried to do and others have tried to do is disrupt that interaction and essentially cause the scaffold to fall apart. And when that falls apart, you can no longer keep those genes on that drive leukemia, and instead, you have genes that essentially cause the cell to stop growing."  #SyndaxPharma #AcuteLeukemia #cGHVD #Oncology #PrecisionMedicine #Menin #MeninInhibitors syndax.com Listen to the podcast here

On this week's Tech Nation, Moira speaks with Warren Berger, author of  “A More Beautiful Question … The Power of Inquiry to Spark Breakthrough Ideas”, now in its tenth anniversary re-release and update. Then, Dr. Peter DeMuth, Chief Scientific Officer at Elicio Therapeutics, tells us about how a treatment can turn into a vaccine and potentially provide long-lasting protection against cancer.

Are wellness retreats just luxury getaways, or can they transform your health? In this episode of the Habits and Hustle podcast, I speak with Dr. Vishal Patel, who explains how most wellness gadgets might be causing more stress than health benefits.  We explore the science behind Sensei's approach, including how thermal imaging can detect muscular imbalances before they cause pain, and why most saunas aren't hot enough to deliver benefits. Dr. Patel debunks popular wellness myths, shares why foot strength is the foundation of longevity, and explains why tracking obsession can be counterproductive.  Dr. Vishal Patel is the Chief Scientific Officer at Sensei, a wellness retreat company co-founded by Larry Ellison and Dr. David Agus. With a background as a physician with a PhD in genetics, Dr. Patel combines Western medicine with Eastern practices like Ayurveda to create evidence-based wellness approaches that focus on personalization rather than rigid rules. What We Discuss:  03:02 Personalized Wellness Programs 05:51 The Science of Eating and Nourishment 08:56 Understanding Body Mechanics for Longevity 12:03 Vishal Patel's Background and Expertise 14:54 Debunking Wellness Myths and Misinformation 20:13 The Science Behind Wellness Trends 25:14 Exploring Infrared Saunas and Their Efficacy 30:00 The Role of Data in Health Tracking 35:29 Understanding Plasmapheresis and Its Implications …and more! Thank you to our sponsors: Therasage: Head over to therasage.com and use code Be Bold for 15% off  TruNiagen: Head over to truniagen.com and use code HUSTLE20 to get $20 off any purchase over $100. Magic Mind: Head over to www.magicmind.com/jen and use code Jen at checkout. Air Doctor: Go to airdoctorpro.com and use promo code HUSTLE for up to $300 off and a 3-year warranty on air purifiers.  Bio.me: Link to daily prebiotic fiber here, code Jennifer20 for 20% off.  David: Buy 4, get the 5th free at davidprotein.com/habitsandhustle.   Find more from Jen:  Website: https://www.jennifercohen.com/ Instagram: @therealjencohen   Books: https://www.jennifercohen.com/books Speaking: https://www.jennifercohen.com/speaking-engagement Find more from Dr. Vishal Patel: Website: https://sensei.com/  LinkedIn: https://www.linkedin.com/in/vishal-n-patel-md-phd/ 

In this episode of the "Metabolic Freedom Podcast," host Ben Azadi sits down with Alessandra Zonari, who is the co-founder and Chief Scientific Officer of OneSkin. They explore the fascinating science behind skin aging, particularly focusing on senescent cells, often referred to as "zombie" cells. These cells tend to build up as we age and play a significant role in skin deterioration. Alessandra shares insights into OneSkin's groundbreaking approach, which involves using the OS1 peptide to reduce these cells and promote healthier skin. They also discuss why it's crucial to have scientific evidence backing skincare products, how lifestyle and environmental factors can affect skin health, and the advantages of using non-toxic ingredients. The episode highlights the importance of making informed skincare choices for overall well-being.

Today we have Dr. Michael A. Schmidt, the founder, CEO, and Chief Scientific Officer of Sovaris Aerospace, a company focused on assessments and solutions applied to humans in space and extreme environments on Earth.  Michael is also a professor of aerospace medicine at the University of Central Florida College of Medicine, one of the few programs in the U.S. that offers a medical residency in aerospace medicine. Michael is known for his work pioneering the field of precision medicine. He uses molecular analytics, coupled with physiologic and behavioral assessments, to facilitate human performance and resilience on Earth as well as in the extreme environment of space. His work covers a spectrum from NASA, the NFL, the NBA, U.S. Olympic teams, Nike, SpaceX, Axiom Space, NASCAR, Special Operations, the Naval Submarine Medical Research Lab, the Mayo Clinic, and others. We had a long and fascinating conversation with Michael and decided to break the interview into two parts. This episode focuses on Michael's background and the cognitive and physical challenges astronauts experience in spaceflight. We also dive into the many ways that precision medicine is facilitating human performance and resilience here on Earth. In part two of our conversation, Michael talks about his work with NASA and SpaceX on the challenges of civilian spaceflight and the future of Mars exploration, including the construction of permanent colonies on the Moon and Mars. You won't want to miss that conversation. Show notes: [00:03:59] Dawn opens our interview mentioning that Michael grew up in Minnesota in a small farming community, asking if it's true that he sometimes had to do chores in 20- to 30-degree weather. [00:06:50] Dawn asks if it is true that Michael fell in love with science at a young age, even building telescopes at the age of 11. [00:08:00] Dawn asks Michael what it was that led him to become so fascinated with space specifically. [00:08:58] Dawn asks if Michael ever thought about becoming an astronaut. [00:10:09] Ken asks if it is true that Michael was a big reader as a child. [00:11:21] Dawn asks Michael to talk about his childhood athletic interests. [00:11:55] Dawn asks how it was that a high school quarterback from a small town in Minnesota ended up at university in the United Kingdom. [00:13:38] Ken asks Michael what years he worked at NASA Ames Research Center. [00:14:51] Ken mentions that when Michael was at NASA Ames, he did work collecting molecular and physiologic assessments of humans using NASA's 20-G centrifuge. Ken asks Michael to talk about the centrifuge and how he used it in his studies of hypergravity. [00:17:49] Ken comments on the fact that pieces of equipment like NASA's 20-G centrifuge are a precious scientific resource, and when they cease functioning, unfortunately, they are unlikely to be replaced. [00:19:40] Ken and Michael discuss the fact that microgravity, despite being one of the most pressing effects on astronaut health, is the one of the least addressed problems in human spaceflight. [00:21:48] Ken explains that Michael is the founder, CEO and Chief Scientific Officer of a company called Sovaris Aerospace, which is focused on assessments and solutions applied to humans in space and extreme environments on Earth. Ken asks Michael where the idea came from to found this company. [00:24:35] Dawn explains that since the human genome was first sequenced, there has been an acceleration of genome-based technologies that have made it possible to consider a person's genetic makeup, both in healthcare and optimizing performance. Dawn asks Michael to talk about the work he does applying genomics to human spaceflight. [00:28:52] Dawn asks about Michael's direction of the molecular profiling and precision medicine efforts for the Golden State Warriors during their record-breaking 73-9 season [00:32:57] Dawn mentions that Michael published a review in the journal Meta...

Peter A McCullough, MD, MPH, Chief Scientific Officer, TWC. Visit twc.health/GRUBER and use Promo Code: GRUBER Secretary Kennedy announced the removal of the COVID vaccine from the CDC's recommended schedule, for 'healthy children and healthy pregnant women."

All Home Care Matters and our host, Lance A. Slatton were honored to welcome the team behind the Dementia Care Family Support Program.   About Denise M. Brown:   Denise began supporting family caregivers in 1990, launching one of the first online caregiving communities in 1996. She trains Caregiving Consultants, Facilitators, Guides and Navigators. She cared for her father for almost 20 years and for her mother for 8 years.   She's written 16 books for current and former family caregivers.    About Dr. Laura Gitlin:   Dr. Laura Gitlin is the Co-founder and Chief Scientific Officer at Plans4Care. She is an intervention scientist with over 40 years of experience in dementia care and research. Dr. Gitlin currently serves as a multiple Principal Investigator on several NIH-funded grants, where she leads the development and testing of innovative interventions to support people living with dementia and their caregivers.   About Eric Jutkowitz, PhD:   Eric Jutkowitz, PhD is the Co-founder and CEO of Plans4Care. He is health services focused on improving the nation's long-term care system. He co-founded Plans4Care to bring evidence-based dementia care out of the university and into the hands of all family caregivers.   About the Dementia Care Family Support Program:   Our Certified Caregiving Consultants partnered with Plans4Care, a technology start-up to offer 5 coaching sessions to dementia family caregivers in order to resolve 3 care challenges.   We'll share what we learned about using technology during coaching sessions, the common care challenges we addressed and the insights we gained from tracking our coaching sessions. We also will talk about what we learned about how to best support dementia family caregivers to help ease their stress and worries.

What does it take to challenge the deadliest brain tumors with sound waves? How do you scale a medtech startup into a multinational clinical company? And what advice can a top neuro-oncology innovator offer to those hoping to follow a similar path? Welcome to Neurocareers: Doing the Impossible! — The podcast where we explore the extraordinary journeys of those advancing the future of neuroscience and neurotechnology. I'm your host, Dr. Milena Korostenskaja. Today we're speaking with Dr. Michael Canney, the Chief Scientific Officer at Carthera, a clinical-stage medtech company revolutionizing brain therapy through therapeutic ultrasound. With over 15 years of experience in MedTech innovation, Dr. Canney specializes in glioblastoma, neurodegenerative diseases, and therapeutic ultrasound drug delivery. He's currently leading the SONOBIRD Phase 3 clinical trial across 40 sites in the U.S. and Europe, pushing the boundaries of what's possible in treating recurrent glioblastoma. Michael's career spans everything from FDA regulatory strategy to high-impact academic collaborations. He's co-authored over 50 peer-reviewed papers in top-tier journals and 14 patent families. But what truly drives him is improving patient outcomes and bringing hope to some of the most challenging areas in brain health. Whether you're curious about clinical trials, neuro-oncology innovations, or carving out your own career in medtech, this conversation is packed with insight and inspiration. Let's dive in! Chapters: 00:00:01 - Revolutionizing Brain Therapy with Ultrasound, Introducing Dr. Michael Canney 00:04:49 - Advancements in Ultrasound for Drug Delivery 00:10:15 - Innovative Ultrasound for Drug Delivery 00:13:49 - Innovative Ultrasound Approach for Tumor Treatment 00:16:02 - Understanding Blood-Brain Barrier Disruption 00:19:28 - Device Overview and Design Features 00:21:32 - Ultrasound Technology for Tumor Treatment 00:24:15 - Device Implantation in Cancer Treatment 00:28:34 - Challenges in Glioblastoma Treatment Trials 00:31:46 - Dr. Michael Canney's Journey into Ultrasound Research 00:36:15 - Starting a Postdoc Journey 00:39:20 - Career Development in Neuroscience 00:43:31 - Building a Startup Team 00:47:38 - Hiring for Clinical Application Specialists 00:52:16 - Growth of Careers in Neurotechnology 00:54:26 - Using AI in Clinical Trials 00:57:13 - Challenges in Medical Device Approval 00:59:41 - Overcoming Challenges in Medical Innovations 01:02:20 - Clinical Trials and Company Information About the Podcast Guest: Michael Canney, Ph.D., is Chief Scientific Officer at Carthera, a clinical-stage medtech company advancing brain therapy through innovative ultrasound-based devices. A co-author of more than 50 peer-reviewed articles, he specializes in neuro-oncology, glioblastoma and neurodegenerative diseases. At Carthera, he is responsible for leading scientific collaborations with academic institutions, organizing U.S. clinical trials and more. Connect with Dr. Canney on LinkedIn: https://www.linkedin.com/in/michael-canney-ph-d-42457b5/ Learn more about Carthera: https://carthera.eu/ Get familiar with the Sonobird clinical trial: https://sonobird.eu/ About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in neurotech and Brain-Computer Interfaces, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news  

On this episode of The Kara Goldin Show, we're joined by Catharine Arnston, Founder, CEO, and Chief Scientific Officer of ENERGYbits®—the pioneering brand bringing the power of algae to the forefront of wellness, energy, and longevity. After a deeply personal experience with a family health crisis, Catharine made it her mission to educate the world about the incredible health benefits of spirulina and chlorella—long before they became trendy.In our conversation, Catharine shares the early days of discovering algae's healing potential, what inspired her to build ENERGYbits, and why she believes algae is the most powerful superfood on the planet. We dive into the science behind spirulina and chlorella, the major obstacles she faced educating consumers, and how she's grown ENERGYbits into a trusted brand used by athletes, biohackers, and wellness seekers worldwide. Catharine also opens up about the resilience it takes to build a movement from scratch, the leadership lessons she's learned, and the habits that keep her going strong.Whether you're a health-focused founder, a nutrition enthusiast, or someone curious about building brands with real mission and impact, this episode is packed with insights you won't want to miss. Now on The Kara Goldin Show. Are you interested in sponsoring and advertising on The Kara Goldin Show, which is now in the Top 1% of Entrepreneur podcasts in the world? Let me know by contacting me at karagoldin@gmail.com. You can also find me @‌KaraGoldin on all networks. To learn more about Catharine Arnston and ENERGYbits®:https://www.instagram.com/energybitshttps://www.linkedin.com/in/catharinearnstonhttps://www.youtube.com/energybitshttps://www.facebook.com/ENERGYbitshttps://www.twitter.com/energybitshttps://www.instagram.com/catharinearnston/https://www.energybits.com Sponsored By:Range Rover Sport - The Range Rover Sport is your perfect ride. Visit RangeRover.com/us/Sport and check it out. Check out our website to view this episode's show notes: https://karagoldin.com/podcast/692

Peter A McCullough, MD, MPH, Chief Scientific Officer, TWC. twc.health/GRUBER. Promo Code GRUBER Saves 10% What came out at the WED May 21 Senate Hearing on Vaccine Myocarditis?

Blockchain Ireland's annual conference serving the blockchain, crypto and Web3 communities, Blockchain Ireland Summit 2025 kicks off this Friday. One of the speakers at the two day conference is Richard Blythman the Co-founder and Chief Scientific Officer of Naptha.AI, a startup building open, decentralised infrastructure for the next generation of AI. Richard's background is in machine learning, engineering, and academic research, and his work focuses on enabling developers to build intelligent agents that can work together, without relying on centralised platforms or Big Tech infrastructure. Ronan recently caught up with Richard. Richard talks about his background, the internet of agents, what naptha does, AI privacy, eu regulation and more.More about Richard Blythman:He previously co-founded Algovera, one of the earliest players in the decentralised AI sector, and holds a PhD in Engineering from Trinity College Dublin. His experience spans from building generative models and digital avatars in Big Tech, to leading research on fluid dynamics, multi-agent coordination, and privacy-preserving AI systems.At Naptha, Richard is exploring how decentralised agent networks could reshape everything from software development to data ownership, and why open standards like MCP are key to unlocking that future.

Today, we have another episode in our series of thoughtfully curated companies. This episode is sponsored by OneSkin, a company founded and led by an all-female team of PhD-level scientists. OneSkin is redefining how we think about aging, starting with the skin, our largest organ. I am delighted to introduce Dr. Alessandra Zonari as our guest today. Dr. Zonari is far from your typical scientist. She is a true visionary with a passion for longevity, skin regeneration, and an occasional karaoke jam. With degrees in biology and stem cell biology and a doctorate in skin regeneration and tissue engineering, Dr. Zonari brings a wealth of knowledge and a fresh perspective to our conversation today. Join us to learn more about OneSkin and how their products can reverse the effects of biological aging, helping your skin become stronger and more resilient as you age. IN THIS EPISODE YOU WILL LEARN: Dr. Zonari shares her mission to understand how skin can age healthier and stronger and reduce the risk of inflammation and diseases.  How the female-led research team at OneSkin brings a unique perspective to skincare How the OneSkin peptide can reverse 2.5 years of biological aging in just five days The unique way in which they test their products and measure biological aging at OneSkin  How estradiol loss during menopause exacerbates the accumulation of senescent cells and causes inflammation Some common misconceptions about skincare for women in perimenopause and menopause How lifestyle choices influence the aging process of the skin  Why we must protect the skin from environmental stressors to slow the aging process  How your skin cells can get reprogrammed to return to a youthful state How OneSkin developed a hair care line to address hair loss and thinning The importance of self-love and nourishing your body  ABOUT OneSkin:  Founded and led by an all-woman team of PhD-level scientists, OneSkin is transforming the way we think about aging, starting with the body's largest organ, the skin. Our proprietary OS-01 (oh ess one) peptide is the first ingredient to reverse the biological age of skin by targeting cellular senescence, a key driver of aging. By targeting cellular senescence, the OS-01 peptide switches off the damaged cells that contribute to lines, wrinkles, and sagging skin. The result? Skin that looks and behaves younger. Our products are designed for young and mature skin, because it is never too early or too late to invest in your skin health! We create next-level skin care. BIO: Alessandra Zonari, PhD, OneSkin Co-Founder & CSO Alessandra is not your typical scientist. She is a visionary with a passion for longevity, skin regeneration, and the occasional karaoke jam. Growing up in a close-knit family in Brazil, Alessandra saw her grandparents struggle with age-related diseases, and she soon became fascinated by the possibility of using stem cells to redefine the aging process. After earning degrees in biology and stem cell biology and a doctorate in skin regeneration and tissue engineering, Alessandra joined OneSkin in 2017 as a founding member and Chief Scientific Officer. Her contributions include 20+ papers, three patents, and the development of their proprietary OS-01 peptide. Connect with Cynthia Thurlow   Follow on X Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Connect with Dr. Alessandra Zonari On the ONESKIN website ONESKIN on Instagram Interested in trying OneSkin for yourself? Visit oneskin.co/CYNTHIA and use code CYNTHIA for 15% off your first purchase!

Episode 051 | Greg Maguire, PhD is the Co-Founder of the SRM Living Foundry at UCSD in San Diego and the Co-Founder & Chief Scientific Officer of NeoGenesis, a wonderful company I talk with my patients about all the time. If you haven't yet listed to episode 047 featuring Christine Preston, that one pairs delightfully with my conversation with Dr. Maguire.Awarded a prestigious Fulbright-Fogarty Fellowship from the National Institutes of Health, Dr. Maguire managed his NIH funded laboratory at UCSD studying tissue degeneration and regeneration, and the role of stem cell released molecules (SRM) through paracrine and autocrine actions to maintain, repair, and regenerate human tissues. His NIH funded studies of systems biology and reverse engineering at UC Berkeley and stem cell biology at UC San Diego led to the development of adult stem cell-based S2RM® technology for the development of therapeutics and medical procedures.Dr. Maguire pursued his graduate training at the University of California, Berkeley, University of Houston, University of Texas, The Marine Biological Labs, Woods Hole, MA, and Cold Spring Harbor Laboratory, NY. He is a former professor of neuroscience and ophthalmology at the University of California, San Diego School of Medicine, a visiting associate professor of physiology at Keio University School of Medicine in Tokyo, Japan, visiting assistant professor of molecular neurobiology at the University of Washington, and a visiting scientist at Massachusetts General Hospital (MGH), at Harvard University.Dr. Maguire has over 100 publications and is currently working on his book entitled, “Spontaneous Stem Cell Healing”.The Above & Beyond Dermatology podcast is grateful to NeoGenesis for the great work they do and for their generous support of this episode. If you're a skin care professional and would like to learn more about helping your customers with NeoGenesis, click here to learn more. If you'd like to learn directly from the NeoGenesis team, text me at 715-391-9774 and I'll be happy to make a warm introduction.Connect with and learn from Greg Maguire & NeoGenesisLearn & Shop NeoGenesisDr. Maguire's Skin Care BlogNeoGenesis Wholesale Partnership for Medical ProfessionalsMore from Dr. Lewellis and Above & Beyond DermatologyNeed a dermatologist? Fill out this short interest form, text or call me at 715-391-9774, or email me at drlewellis@aboveandbeyondderm.com if you'd like to have a no obligation discovery call. I offer in-office visits, house calls, and virtual care in Wisconsin and virtual care in Illinois, Nebraska, and Colorado.Have an idea for a guest or want to be on the show yourself? Send me a text or email, and we'll see if it's a good fit.

CareQuest Institute for Oral Health is a national nonprofit dedicated to creating an oral health care system that is accessible, equitable, and integrated. Learn more about how their advocacy, philanthropy, research, and education are creating a better oral health system at carequest.org/turnonthelights What happens when the power of large language models meets the complexity of modern medicine? In this episode, Eric Horvitz, Chief Scientific Officer of Microsoft, discusses the transformative impact of artificial intelligence in health care, particularly the shift from rule-based systems to data-driven models like GPT-4. He highlights how AI can reduce physician burnout by handling administrative tasks and supporting clinical decision-making. Eric emphasizes the importance of AI collaborating with, rather than replacing, health care professionals to improve diagnostic accuracy and patient safety. He also explores future possibilities, including personalized health companions, intelligent patient portals, and AI-powered tumor board simulations. Overall, he underscores both the exciting potential and the responsibility involved in integrating AI safely and meaningfully into health care. Tune in for a thought-provoking conversation on how AI is transforming health care, from easing clinician burden to reimagining patient care and medical decision-making! Learn more about your ad choices. Visit megaphone.fm/adchoices

Peter A McCullough, MD, MPH, Chief Scientific Officer, The Wellness Company  twc.health/GRUBER | Promo Code GRUBER Saves 10% Spaces Event TONIGHT (5/7) on The Steve Gruber Show X account  RFK Jr announces a new “Take Control of Your Health” campaign "We Need a Great Reset in Health" The need to stockpile prescription medication

We catch up on the tri news and racing from the weekend and give our thoughts on the announcement that the IM World Champs is moving back to Kona. Alison Heather is a former academic professor whose research has focused for over 24 years' on the physiology of steroid hormones and their role in health and disease. She has international recognition for her development of bioassays for the detection of steroid hormones. Alison acts as an advisor to many High Performance Sport Teams including those focusing on female athlete health, triathlon, cycling, running and sports supplements and is currently the Chief Scientific Officer for plasmaide In this conversation, we discuss the supplement Plasmaide, its origins and its benefits for athletes. Dr Heather explains the science behind nitric oxide production, the ingredients in Plasmaide and how it compares to other supplements like beetroot juice. The discussion covers both acute and chronic benefits of Plasmaide, its adaptogenic properties and its influence on carbohydrate metabolism. Dr. Heather also provides practical advice for using Plasmaide safely and effectively, emphasizing the importance of consulting with a healthcare professional before starting any new supplement regimen. (0:00:00) – A weekend of bike crashes (0:09:22) – T100 goes to the Gold Coast in 2026 (0:15:51) – The racing from IM703 Venice and IRONMAN Australia  (0:24:16) – IRONMAN World Champs moves back to Kona (0:40:05) – Dr Alison Heather intro (0:41:38) – Dr Alison Heather LINKS: Dr Alison Heather at https://www.insitugen.com/ Plasmaide at https://plasmaide.com.au/ Live Feisty podcast at https://livefeisty.com/podcasts/feistytriathlon/ironman-goes-backwards-special-world-champs-episode/ Pro Tri News podcast at https://protrinews.buzzsprout.com/1736374/episodes/17067560-episode-217-kona-is-back-with-ironman-ceo-scott-derue 2025 Oceania Triathlon Super-Sprint Championships Runaway Bay at  https://triathlon.org/events/2025-oceania-triathlon-super-sprint-championships-

Congressman Glenn Grothman from Wisconsin sheds light on the pressing issues surrounding immigration and judicial reform. Grothman discusses the alarming trend of unaccompanied migrant children going missing and criticizes the Democratic Party's stance on illegal immigration. He also addresses the challenges within the judiciary, highlighting concerns about radical judges and the impact of their decisions on American law. Additional interview with Dr. Peter McCullough, Chief Scientific Officer at The Wellness Company, who sounds the alarm on the rise of autism rates in America, as highlighted by HHS Secretary RFK Jr. and supported by new data. Finally, Senior policy analyst Andrés Martínez-Fernández from the Heritage Foundation provides insights on President Trump's recent meeting with El Salvador's President Nayib Bukele, focusing on their agreement to address the challenges of illegal immigration and criminal activity in the U.S.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

EP 205: Catharine Arnston, founder and Chief Scientific Officer of ENERGYbits, is back for another fascinating conversation—this time focused on women's health, hormones, and the power of algae. We dive into how spirulina and chlorella support mitochondrial function, balance hormones, and deliver potent antioxidant benefits, all grounded in decades of research. Catharine's passion for algae began when her sister fell ill, sparking a journey that led to the creation of ENERGYbits. Her deep knowledge and infectious enthusiasm make this a must-listen for anyone curious about how a simple, sustainable superfood can make a big impact. Check Out ENERGYbits | Click Here & use code DRTYNA for 20% off Topics Discussed:  How does algae support women's hormonal health and balance? What are the benefits of spirulina and chlorella for mitochondrial function? Can algae help with symptoms of perimenopause and menopause? Why is algae considered one of the most nutrient-dense superfoods? How do antioxidants in algae improve overall health and energy levels? On This Episode We Cover:  00:00:00 - Introduction  00:02:20 - Manufacturing process  00:04:22 - Different types of algae  00:06:37 - Manufacturing process 00:12:49 - Vegan collagen  00:14:43 - Mitochondrial health & estrogen  00:19:32 - Perimenopause 00:26:11 - Women's aging & hormone health  00:28:49 - Estrogen levels  00:34:55 - Dr. Tyna's experience with ENERGYbits  00:38:04 - Carnivore diet & chlorophyll  00:40:50 - Red light  00:45:43 - B Vitamins & decision fatigue  00:47:31 - Constipation  00:49:53 - Aging and finding joy  00:56:04 - Testimonials  Further Listening:  EP. 139: Algae 101 | Catharine Arnston of Energy Bits Hormones Playlist Sponsored By: ENERGYbits | Click Here & use code DRTYNA for 20% off Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.